Tennessee HB1968 amends opioid-related laws to include additional pharmaceutical companies.
Tennessee HB1968 amends Tennessee Code Annotated, Title 20 and Title 33, relative to opioids by updating the list of pharmaceutical companies subject to certain opioid regulations. The bill replaces references to "Purdue Pharma L.P." with "Purdue Pharma L.P., Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc." in relevant sections. This change ensures that the updated list of companies is subject to the same regulatory requirements. The act includes a severability clause, ensuring that invalid provisions do not affect the rest of the act.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.